| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10% | $521,644 | 283,502 | Armistice Capital, LLC | 31 Dec 2025 | |||
| SABBY MANAGEMENT, LLC | 9.9% | $493,974 | 217,600 | SABBY MANAGEMENT, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 8 institutional investors reported holding 305,273 shares of Biodexa Pharmaceuticals Plc - American Depositary Shares, each representing four hundred ordinary shares (BDRX). This represents 11% of the company’s total 2,837,858 outstanding shares.
The largest institutional shareholders of Biodexa Pharmaceuticals Plc - American Depositary Shares, each representing four hundred ordinary shares (BDRX) together control 11% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 6.7% | 190,658 | 3.6% | $432,794 | |
| ARMISTICE CAPITAL, LLC | 3.5% | 100,000 | 0.01% | $227,000 | |
| HRT FINANCIAL LP | 0.37% | 10,583 | 0% | $24,000 | |
| UBS Group AG | 0.07% | 2,100 | -70% | 0% | $4,767 |
| GAMMA Investing LLC | 0.06% | 1,777 | +31% | 0% | $4,034 |
| SBI Securities Co., Ltd. | 0% | 101 | -12% | 0% | $229 |
| Hilton Head Capital Partners, LLC | 0% | 30 | 0% | 0% | $68 |
| RHUMBLINE ADVISERS | 0% | 24 | +380% | 0% | $54 |